These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1250190)

  • 21. [Control of heparinization in the hemodialysis for acute kidney failure].
    Vogel GE; Goldmann FL; Jelen S; Tempel G
    Med Welt; 1977 May; 28(19):899-902. PubMed ID: 881979
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of umbilical artery catheter clots with heparinized infusates.
    David RJ; Merten DF; Anderson JC; Gross S
    Dev Pharmacol Ther; 1981; 2(2):117-26. PubMed ID: 7472106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of intraoperative heparinization in vascular surgery.
    Manny J; Romanoff H; Hyam E; Manny N
    Surgery; 1976 Nov; 80(5):641-3. PubMed ID: 982283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-blood thrombin time: a bedside method for determination of heparin activity.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1976 Dec; 6(6):523-5. PubMed ID: 1009699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory management of the bleeding patient.
    Taylor LJ
    Clin Lab Sci; 2003; 16(2):111-4. PubMed ID: 12757191
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mixing test for prolonged clotting time: clinical availability and problems].
    Uchiba M; Ando Y
    Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alterations in coagulation following heparinization during transvenous cardiac catheterizations in children (author's transl)].
    Schreiber R; Schumacher G; Bühlmeyer K
    Klin Padiatr; 1979 Jan; 191(1):24-32. PubMed ID: 569730
    [No Abstract]   [Full Text] [Related]  

  • 35. Tight heparin regimen for haemodialysis in children.
    Ozen S; Saatçi U; Bakkaloğlu A; Uyumaz H; Kavukçu S
    Int Urol Nephrol; 1993; 25(5):499-501. PubMed ID: 8270379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Haemodialysis in acute renal failure; technique and surveillance (author's transl)].
    Köhler R; Lehmann C; Osswald M
    Prakt Anaesth; 1978 Jun; 13(3):191-6. PubMed ID: 724626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rebound anticoagulation occurring after regional heparinization for hemodialysis.
    Blaufox MD; Hampers CL; Merrill JP
    Trans Am Soc Artif Intern Organs; 1966; 12():207-9. PubMed ID: 5960705
    [No Abstract]   [Full Text] [Related]  

  • 38. Coagulant activity deposited on the Kiil haemodialysis membranes.
    Lurie A; Denson KW
    Thromb Diath Haemorrh; 1970 Dec; 24(3):572-6. PubMed ID: 5534488
    [No Abstract]   [Full Text] [Related]  

  • 39. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.